About

Publications While At HealthPartners

selected publications

Journal Article

Association of fenofibrate therapy with long-term cardiovascular risk in statin-treated patients with type 2 diabetes. 

JAMA cardiology. 2017

Paradoxical reduction in HDL-C with fenofibrate and thiazolidinedione therapy in type 2 diabetes: the ACCORD Lipid Trial. 

Diabetes care. 2014

Fenofibrate-associated changes in renal function and relationship to clinical outcomes among individuals with type 2 diabetes: the Action to Control Cardiovascular Risk in Diabetes (ACCORD) experience. 

Diabetologia. 2012

Reversibility of fenofibrate therapy-induced renal function impairment in ACCORD type 2 diabetic participants. 

Diabetes care. 2012

Effects of combination lipid therapy in type 2 diabetes mellitus. 

New England Journal of Medicine. 2010

Effects of medical therapies on retinopathy progression in type 2 diabetes. 

New England Journal of Medicine. 2010

Evolution of the lipid trial protocol of the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial Am J Cardiol

2007

presentations

Presentation

Hypertriglyceridemia and low HDL-C predicts fenofribrate response in the ACCORD-Lipid Trial [presentation], American Heart Association (AHA) Scientific Sessions

Contact

full name

M. B. Elam

MB Elam

Quick Info

 

Collaboration

Co-author network

Map of science